Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Learn about wealth accumulation strategies specifically designed for high earners to maximize their income and savings potential. Start maximizing your wealth.
24,270 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Adobe stock sits around $195 after a dramatic retreat from its 52-week high, prompting investors to weigh whether the...
A leading south korean digital bank launches a Solana-based PoC to move funds across borders, testing stablecoin remi...
Rivian shares traded near $14.90 as macro headwinds pressure EV names, while a still-growing VW software venture keep...
A director at AMN Healthcare recently disclosed selling about 3,681 shares for roughly $114,000 as the stock jumped 4...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Apple stock has turned heads for years with strong profitability and a steady drip of shareholder rewards. This artic...
A leading analyst has reiterated a $250 SpaceX target, arguing that SpaceX's physical AI capabilities could reshape r...
A strong earnings backdrop and improving fundamentals may be signaling a shift for Micron stock. This guide breaks do...
A trusted pastor’s name was weaponized in a modern scam that asked church members to buy gift cards. This guide expla...
SRLN’s monthly distributions appear steady, but a falling-rate regime is quietly compressing income from its floating...
OpenAI accelerates its shift from software to silicon and bio bets, unveiling a custom chip, a DRAM stake, and a majo...